Landsea Homes Corporation 

41,301,645 Shares of Common Stock 

5,500,000 Warrants to Purchase Common Stock

This prospectus supplement no. 12 is being filed to update and supplement information contained in the prospectus dated March 19, 2021 (the “Prospectus”) related to: (1) the issuance by us of up to 7,052,500 shares of our common stock, par value $0.0001 per share (“Common Stock”) that may be issued upon exercise of warrants to purchase Common Stock at an exercise price of $11.50 per share of Common Stock, including the public warrants and the Private Placement Warrants (as defined in the Prospectus); and (2) the offer and sale, from time to time, by the Selling Holders (as defined in the Prospectus) identified in the Prospectus, or their permitted transferees, of (i) up to 41,301,645 shares of Common Stock and (ii) up to 5,500,000 Private Placement Warrants, with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission on November 16, 2021 (the “Current Report”). Accordingly, we have attached the Current Report to this prospectus supplement. Any document, exhibit or information contained in the Current Report that has been deemed furnished and not filed in accordance with Securities and Exchange Commission rules shall not be included in this prospectus supplement.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and any prior amendments or supplements thereto and if there is any inconsistency between the information therein and this prospectus supplement, you should rely on the information in this prospectus supplement.

Our Common Stock and warrants are traded on the Nasdaq Global Market under the symbols “LSEA” and “LSEAW,” respectively. On November 15, 2021, the closing price of our Common Stock was $8.64 per share and the closing price of our warrants was $0.2501 per warrant.

Investing in our securities involves risks. See “Risk Factors” beginning on page 16 of the Prospectus and in any applicable prospectus supplement.

Neither the Securities and Exchange Commission nor any other regulatory body have approved or disapproved these securities, or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is November 16, 2021.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 15, 2021

LANDSEA HOMES CORPORATION

(Exact name of registrant as specified in its charter)

Registrant’s telephone number, including area code: (949) 345-8080

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 15, 2021, the Board of Directors (the “Board”) of Landsea Homes Corporation (the “Company”) appointed Christopher Porter, age 55, to serve as the Chief Financial Officer of the Company, effective as of December 7, 2021 (the “Appointment Effective Date”). In that role, Mr. Porter will serve as the Company’s principal financial officer. Mr. Porter will oversee accounting, treasury, capital markets, investor relations and financial forecasting for the Company. Mr. Porter has over 18 years of experience in the commercial real estate industry, with over 30 years extensive experience in all accounting and finance across multiple industries. Prior to joining the Company, Mr. Porter served as President and Chief Financial Officer of Silverstone Healthcare Company, a senior housing real estate development company since November 2013. From February 2010 to October 2013, Mr. Porter served as Vice President and Treasurer of Dyn-Corp International, an American private military contractor, and was responsible for its global treasury, risk management, liquidity and investor relations functions. Mr. Porter spent the previous 10 years at Crescent Real Estate Equities, ending as Managing Director, in charge of Capital Markets, Risk Management and Treasury. Mr. Porter holds a Bachelor of Arts in Economics from the University of Texas at Austin and Master of Business Administration from the University of North Texas.

In connection with the appointment of Mr. Porter, John Ho, the Company’s Chief Executive Officer and Interim Chief Financial Officer, will cease to serve as the Interim Chief Financial Officer on the Appointment Effective Date but will continue to serve as the Company’s Chief Executive Officer.

In connection with the appointment of Mr. Porter, the Company has entered into an executive employment agreement with him to be effective on the Appointment Effective Date (the “Executive Agreement”). The Executive Agreement provides for an initial term ending December 31, 2023, which will automatically renew for successive one-year terms thereafter unless either party gives written notice of non-extension. Under the Executive Agreement, Mr. Porter will receive an annual base salary of $450,000 and will have a target annual bonus for 2022 of $350,000 and a target annual equity incentive award for 2022 with an expected value on the date of grant of approximately $300,000.

In addition, the Executive Agreement provides for certain severance benefits upon a qualifying termination, which includes a termination by the Company without Cause (as defined in the Executive Agreement) (and not as a result of death or disability) or a resignation for Good Reason (as defined in the Executive Agreement). Upon such qualifying termination, Mr. Porter would be eligible to receive: (i) a lump sum cash amount equal to 1.0x (or 2.0x if such termination occurs within 24 months following a change in control) the sum of his base salary and target annual bonus; (ii) a pro-rata portion of his annual bonus for the year of termination based on actual performance; (iii) payment of or reimbursement for premiums to continue health coverage for 24 months (unless the NEO becomes eligible for coverage under another employer’s plan, at which time the reimbursements will cease); and (iv) full acceleration of any outstanding equity awards, with performance-based awards determined based on the terms of the applicable award agreement or, if the award agreement does not specify, based on the target level of performance.

In the event of a termination as a result of death or disability, Mr. Porter (or his beneficiary or estate) is eligible to receive a pro-rata portion of his target bonus for the year of termination and full acceleration of any outstanding equity awards, with performance-based awards determined based on the terms of the applicable award agreement or, if the award agreement does not specify, based on the target level of performance.

The foregoing severance benefits under the Executive Agreement are subject to Mr. Porter’s execution of a release of claims. The foregoing description of the Executive Agreement is qualified in its entirety by reference to the full text of the Executive Agreement, which is attached Exhibit 10.1 to this Current Report on Form 8-K.

In connection with Mr. Porter’s appointment as Chief Financial Officer, Mr. Porter is expected to enter into the Company’s standard form of indemnification agreement. Pursuant to the terms of the indemnification agreement, the Company may be required, among other things, to indemnify Mr. Porter for certain expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by him in any action or proceeding arising out of his service as an officer of the Company.

Mr. Porter has (i) no family relationship with any director or other executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer; (ii) is not a party to any related person transaction with the Company; and (iii) has no arrangements or understandings with any other person pursuant to which he was appointed as Chief Financial Officer of the Company.

A copy of the Company's press release announcing the appointment of Mr. Porter is attached as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.